Topic Archives: Regeneron (REGN)

I’ve gotten a few questions about the latest Technology Profits Confidential (currently $79/yr) tease from Ray Blanco, so although it’s a few weeks old now, and started circulating right in the heat of the first coronavirus downturn in mid-March, I thought I’d take a look today. It is still a current ad, I got it […]

This particular bit of news leaves your friend Doc Gumshoe shaking his head in puzzlement.  To wit, in the US it is expected that there will be a substantial shortage of physicians in the upcoming years.   The American Association of Medical Colleges predicts that this shortage may reach about 122,000 physicians by the year […]

[Ed. Note: Dr. KSS writes about medicine and biotech stocks for the Irregulars. He has agreed to our trading restrictions, chooses his own topics, and his words and opinions are his own. All of his past articles and most recent comments are on his Stock Gumshoe page.] “Thanks to you I’m much obliged Such a […]

[Ed. Note: Dr. KSS writes about medicine and biotech stocks for the Irregulars. He choses his own topics, his words and opinions are his own, and he has agreed to our trading restrictions. You can see his Stock Gumshoe page here.] When I was an undergraduate student, I became a good friend of Michael D., […]

[ed note: Michael Jorrin, who I like to call “Doc Gumshoe”, is a longtime medical writer (not a doctor) who shares his thoughts with us from time to time, generally on non-financial topics in health and medicine (as today, though, he mentions a couple publicly traded companies). His words and opinions are his own.] The […]

[ed note: Dr. KSS is a paid contributor to Stock Gumshoe who writes about biotech stocks for (and discusses them with) the Irregulars. He chooses his own topics, and his words and opinions are his alone. Enjoy!] Greetings fellow Irregulars!  You’ve all been waiting for it….our first-ever annual ceremony in which we look back on […]

[Ed. Note: Dr. KSS writes about medical topics and biotech stocks for the Irregulars. He has agreed to our trading restrictions, and his thoughts and words are his own. Enjoy!] Any discussion of cholesterol immediately turns Brobdingnagian, such are the extremes in question. Statins, which lower LDL cholesterol, are bombastically the best-selling drugs of all […]

Comments

  • Avatar

    I subscribed to the charter offer for the sole reason of zero risk and to get access to his video course being offered t...

  • Avatar

    Asked this question in another post but figured I'll ask it again here. Whitney Tilson is offering a new flagship news...

  • Avatar

    Forgot to mention their Charter lifetime membership pricing was $5000 with a $199 maintenance fee....

  • Avatar

    Completely agree that the $2500 promotional pricing (and especially $5000 annual) for Whitney's flagship offering is ou...

  • Avatar

    For whatever this is info is worth, Whitney Tilson -- allegedly considered by peers and politicians as a "prophet" of Wa...

  • Travis Johnson, Stock Gumshoe

    The only analysis I've read recently on EXAS was negative, the short argument made by Whitney Tilson and others, and I k...

  • Avatar

    YOU ARE LUCKY YOU COULDNT BUY. QCOR BUY OUT. Whitney Tilson talked twice, for a total of about four hours (he’...

  • Travis Johnson, Stock Gumshoe

    They're too small to have any real analyst coverage -- even if there was an analyst on this little name, odds are good t...

  • Avatar

    I was kinda interested until you mentioned Whitney Tilson. Banks are too big to fail, but that doesn't mean that they c...

  • We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.

    More Info